A breath of life for inhaled insulin: Severe subcutaneous insulin resistance as an indication?

Pediatric Diabetes

Volumn 11, Issue 6, 2010, Pages 377-379

  Mastrandrea, Lucy D ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; HEMOGLOBIN A1C; HEPARIN; INSULIN; RECOMBINANT HUMAN INSULIN;

CASE REPORT; CHILD; CIGARETTE SMOKING; CONTINUOUS INFUSION; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DRUG APPROVAL; DRUG FORMULATION; DRUG WITHDRAWAL; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN TREATMENT; LUNG CANCER; MALE; PATIENT COMPLIANCE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SEPSIS; SUBCUTANEOUS INSULIN RESISTANCE SYNDROME; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT RESPONSE;

ADMINISTRATION, INHALATION; CHILD; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN RESISTANCE;

EID: 77956102653     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00713.x     Document Type: Editorial

References (16)

1. Ahern JA, Boland EA, Doane R. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age-groups. Pediatr Diabetes 2002, 3:10-15..
2. Litton J, Rice A, Friedman N, Oden J, Lee MM, Freemark M. Insulin pump therapy in toddlers and preschool children with type 1 diabetes mellitus. J Pediatr 2002, 141:490-495..
3. Pickup JC, Keen H, Parsons JA, Alberti KG. Continuous subcutaneous insulin infusion: an approach to achieving normoglycemia. Br Med J 1978, 1:204-207..
4. Owen S. Pediatric pumps: barriers and breakthroughs. Diabetes Educ 2006, 32S:29S-38S..
5. Paulsen EP, Courtney JW, Duckworth WC. Insulin resistance caused by massive degradation of subcutaneous insulin. Diabetes 1979, 28:640-645..
6. van Alfen-van der Velden AAEM, Noordam C, de Galan BE, Hoorweg-Nigman JJG, Voorhoeve PG, Westerlaken C. Successful treatment of severe subcutaneous insulin resistance with inhaled insulin therapy. Pediatr Diabetes 2010, 11:380-382.
7. Tokuyama Y, Nozaki O, Kanatsuka A. A patient with subcutaneous-insulin resistance treated by insulin lispro plus heparin. Diabetes Res Clin Pract 2001, 54:209-212..
8. Soudan B, Girardot C, Fermon C, Verlet E, Pattou F, Vantyghem MC. Extreme subcutaneous insulin resistance: a misunderstood syndrome. Diabetes Metab 2003, 29:539-546..
9. Schade DS, Duckworth WC. In search of the subcutaneous-insulin-resistance syndrome. N Engl J Med 1986, 315:147-153..
10. Kawashima S, Kaneto H, Sakamoto K. Dramatic improvement of subcutaneous insulin resistance with nafamostat ointment treatment. Diabetes Care 2008, 31:e11..
11. Skyler JS, Weinstock RS, Raskin P. Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial. Diabetes Care 2005, 28:1630-1635..
12. Hollander PA, Blonde L, Rowe R. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes. Diabetes Care 2004, 27:2356-2362..
13. Heinemann L. The failure of Exubera: are we beating a dead horse? J Diabetes Sci Technol 2008, 2:518-529..
14. Kling J. Inhaled insulin's last gasp? Nat Biotechnol 2008, 26:479-480..
15. Rave K, Bott S, Heinemann L. Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin. Diabetes Care 2005, 28:1007-1082..
16. Koro CE, Bowlin SJ, Bourgeios N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care 2004, 27:17-20..